This paper is in the following e-collection/theme issue:

Cyberpharmacies (40) JMIR Theme Issue: COVID-19 Special Issue (2391) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1482) Drug Repurposing and Off-Label Use (23) Adverse Drug Events Detection, Pharmacovigilance and Surveillance (146) Infectious Diseases (non-STD/STI) (1485) Outbreak and Pandemic Preparedness and Management (1675) Information Seeking, Information Needs (424) Infoveillance and Social Listening (181)
Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/27704, first published .
COVID-19 Treatments Sold Online Without Prescription Requirements in the United States: Cross-sectional Study Evaluating Availability, Safety and Marketing of Medications

COVID-19 Treatments Sold Online Without Prescription Requirements in the United States: Cross-sectional Study Evaluating Availability, Safety and Marketing of Medications

COVID-19 Treatments Sold Online Without Prescription Requirements in the United States: Cross-sectional Study Evaluating Availability, Safety and Marketing of Medications

Authors of this article:

Sachiko Ozawa1, 2 Author Orcid Image ;   Joanna Billings1 Author Orcid Image ;   Yujiao Sun1 Author Orcid Image ;   Sushan Yu1 Author Orcid Image ;   Benjamin Penley1 Author Orcid Image
Article Authors Cited by (13) Tweetations (4) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.